MX156438A - Procedimiento para la preparacion de un complejo mixto de tiazida y resina ionica - Google Patents
Procedimiento para la preparacion de un complejo mixto de tiazida y resina ionicaInfo
- Publication number
- MX156438A MX156438A MX203512A MX20351284A MX156438A MX 156438 A MX156438 A MX 156438A MX 203512 A MX203512 A MX 203512A MX 20351284 A MX20351284 A MX 20351284A MX 156438 A MX156438 A MX 156438A
- Authority
- MX
- Mexico
- Prior art keywords
- thiazide
- salts
- achieve
- thiazides
- administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Eye Examination Apparatus (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Medicines Containing Plant Substances (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/559,755 US4898729A (en) | 1983-12-09 | 1983-12-09 | Treatment of hypertension, compounds and compositions for antihypertension and diuresis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX156438A true MX156438A (es) | 1988-08-22 |
Family
ID=24234891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX203512A MX156438A (es) | 1983-12-09 | 1984-11-28 | Procedimiento para la preparacion de un complejo mixto de tiazida y resina ionica |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4898729A (es) |
| EP (1) | EP0154009B1 (es) |
| JP (4) | JPS60139620A (es) |
| AT (1) | ATE91416T1 (es) |
| AU (2) | AU564078B2 (es) |
| CA (1) | CA1279575C (es) |
| DE (1) | DE3486177T2 (es) |
| DK (1) | DK586784A (es) |
| FI (1) | FI844593L (es) |
| GR (1) | GR81209B (es) |
| IE (1) | IE60713B1 (es) |
| IL (1) | IL73422A0 (es) |
| IN (1) | IN162797B (es) |
| MX (1) | MX156438A (es) |
| NZ (1) | NZ210056A (es) |
| PT (1) | PT79604B (es) |
| ZA (1) | ZA848619B (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01502816A (ja) * | 1986-05-02 | 1989-09-28 | ジーエーエフ・コーポレーション | 水溶性ポリビニルラクタムー薬剤複合体 |
| US4894239A (en) * | 1987-06-02 | 1990-01-16 | Takeda Chemical Industries, Ltd. | Sustained-release preparation and production thereof |
| US5132296A (en) * | 1987-08-14 | 1992-07-21 | Cherksey Bruce D | Membrane NA+ channel protein and related therapeutic compounds |
| EP0418597A3 (en) * | 1989-09-21 | 1991-11-27 | American Cyanamid Company | Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form |
| KR100221695B1 (ko) * | 1991-08-12 | 1999-09-15 | 그린 마틴, 브라이언 쥐 테슬리 | 약학적 구상 제형 |
| US5721263A (en) * | 1993-06-07 | 1998-02-24 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition for angiotensin II-mediated diseases |
| US5994348A (en) * | 1995-06-07 | 1999-11-30 | Sanofi | Pharmaceutical compositions containing irbesartan |
| US5980882A (en) * | 1997-04-16 | 1999-11-09 | Medeva Pharmaceuticals Manufacturing | Drug-resin complexes stabilized by chelating agents |
| ES2235854T3 (es) * | 1999-04-05 | 2005-07-16 | Emisphere Technologies, Inc. | Sales disodicas, monohidratos y solvatos etanolicos para aportar agentes activos. |
| US8168616B1 (en) | 2000-11-17 | 2012-05-01 | Novartis Ag | Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension |
| EP1250937B1 (en) * | 2001-04-09 | 2009-05-13 | Rohm And Haas Company | Controlled dissolution of active ingredients |
| US8563592B2 (en) | 2001-11-01 | 2013-10-22 | Spectrum Pharmaceuticals, Inc. | Bladder cancer treatment and methods |
| ES2341922T3 (es) | 2001-11-01 | 2010-06-29 | Spectrum Pharmaceuticals, Inc. | Composiciones medicas para el tratamiento intravesical de cancer de vejiga. |
| GB0325605D0 (en) * | 2003-11-03 | 2003-12-10 | Novartis Ag | Combination of organic compounds |
| WO2007092963A1 (en) * | 2006-02-09 | 2007-08-16 | Spectrum Pharmaceuticals, Inc. | Bladder cancer treatment involving determination of tumor enzyme level |
| KR101368997B1 (ko) * | 2009-10-20 | 2014-03-03 | 재단법인 의약바이오컨버젼스연구단 | 벤즈티아지드를 유효성분으로 함유하는 항암용 조성물 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL247297A (es) * | 1959-01-14 | |||
| US3781430A (en) * | 1962-10-30 | 1973-12-25 | Merck & Co Inc | Diuretic formulations |
| FR3608M (fr) * | 1964-02-03 | 1965-10-11 | Merck & Co Inc | Compositions diurétiques. |
| NL7508856A (nl) * | 1974-08-16 | 1976-02-18 | Merck & Co Inc | Werkwijze voor het bereiden van preparaten tegen hypertensie. |
| FR2314719A1 (fr) * | 1975-04-11 | 1977-01-14 | Roussel Uclaf | Nouveau medicament notamment diuretique |
| GB1525296A (en) * | 1975-08-04 | 1978-09-20 | Geistlich Soehne Ag | Antibacterial compositions |
| DE2546577B2 (de) * | 1975-10-17 | 1981-04-02 | Sandoz-Patent-GmbH, 7850 Lörrach | Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden |
| GB1509778A (en) * | 1975-10-29 | 1978-05-04 | Leo Pharm Prod Ltd | Pharmaceutical composition and dosage units thereof |
| DE2638716A1 (de) * | 1976-08-27 | 1978-03-02 | Ici Gmbh | Antihypertensiva |
| CA1120400A (en) * | 1977-12-27 | 1982-03-23 | Zola P. Horovitz | Method of treating hypertension and medicaments therefor |
| CH639273A5 (de) * | 1978-09-12 | 1983-11-15 | Hoffmann La Roche | Diuretische mittel. |
| DE3027392A1 (de) * | 1980-07-17 | 1982-02-04 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Synergistische kombination eines (beta) -rezeptorenblockers mit einem saluretikum |
| DE3041812A1 (de) * | 1980-11-06 | 1982-06-16 | Hoechst Ag, 6000 Frankfurt | Basisch substituierte 5-phenyltetrazole, verfahren zu ihrer herstellung und ihre verwendung als heilmittel |
| JPS5788117A (en) * | 1980-11-21 | 1982-06-01 | Smithkline Corp | Gelatin capsule containing triamterene |
| JPS5933213A (ja) * | 1982-07-27 | 1984-02-23 | ミラン・フア−マスウ−テイカルズ・インコ−ポレイテイド | 医薬組成物及びその製造方法 |
| JPS5927812A (ja) * | 1982-08-05 | 1984-02-14 | Kotobuki Seiyaku Kk | ニフエジピン製剤の製造方法 |
| JPS5982314A (ja) * | 1982-10-29 | 1984-05-12 | インステイテユト・オルガニチエスコゴ・シンテザ・アカデミイ・ナウク・ラトビイスコイ・エスエスア−ル | 抗菌性医薬組成物 |
-
1983
- 1983-12-09 US US06/559,755 patent/US4898729A/en not_active Expired - Lifetime
-
1984
- 1984-10-29 IN IN760/CAL/84A patent/IN162797B/en unknown
- 1984-10-31 NZ NZ210056A patent/NZ210056A/xx unknown
- 1984-11-05 ZA ZA848619A patent/ZA848619B/xx unknown
- 1984-11-05 IL IL73422A patent/IL73422A0/xx unknown
- 1984-11-16 CA CA000468042A patent/CA1279575C/en not_active Expired - Fee Related
- 1984-11-22 FI FI844593A patent/FI844593L/fi not_active Application Discontinuation
- 1984-11-28 MX MX203512A patent/MX156438A/es unknown
- 1984-12-03 PT PT79604A patent/PT79604B/pt not_active IP Right Cessation
- 1984-12-07 GR GR81209A patent/GR81209B/el unknown
- 1984-12-07 AU AU36414/84A patent/AU564078B2/en not_active Ceased
- 1984-12-07 AT AT84114906T patent/ATE91416T1/de not_active IP Right Cessation
- 1984-12-07 EP EP84114906A patent/EP0154009B1/en not_active Revoked
- 1984-12-07 DE DE84114906T patent/DE3486177T2/de not_active Expired - Fee Related
- 1984-12-07 IE IE314884A patent/IE60713B1/en not_active IP Right Cessation
- 1984-12-07 JP JP59257718A patent/JPS60139620A/ja active Pending
- 1984-12-07 DK DK586784A patent/DK586784A/da not_active Application Discontinuation
-
1987
- 1987-06-16 AU AU74402/87A patent/AU602899B2/en not_active Ceased
-
1996
- 1996-02-08 JP JP8022896A patent/JPH08253418A/ja active Pending
- 1996-08-27 JP JP8225593A patent/JPH09278655A/ja active Pending
-
1997
- 1997-08-04 JP JP9209232A patent/JPH10152441A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US4898729A (en) | 1990-02-06 |
| JPS60139620A (ja) | 1985-07-24 |
| JPH08253418A (ja) | 1996-10-01 |
| JPH09278655A (ja) | 1997-10-28 |
| AU602899B2 (en) | 1990-11-01 |
| DK586784D0 (da) | 1984-12-07 |
| DE3486177D1 (de) | 1993-08-19 |
| ATE91416T1 (de) | 1993-07-15 |
| GR81209B (en) | 1985-04-10 |
| IN162797B (es) | 1988-07-09 |
| FI844593L (fi) | 1985-06-10 |
| JPH10152441A (ja) | 1998-06-09 |
| EP0154009B1 (en) | 1993-07-14 |
| DE3486177T2 (de) | 1994-03-10 |
| IE60713B1 (en) | 1994-08-10 |
| AU7440287A (en) | 1987-10-08 |
| DK586784A (da) | 1985-06-10 |
| AU564078B2 (en) | 1987-07-30 |
| AU3641484A (en) | 1985-06-13 |
| CA1279575C (en) | 1991-01-29 |
| ZA848619B (en) | 1985-06-26 |
| EP0154009A1 (en) | 1985-09-11 |
| PT79604B (en) | 1986-11-18 |
| IL73422A0 (en) | 1985-02-28 |
| NZ210056A (en) | 1989-01-06 |
| PT79604A (en) | 1985-01-01 |
| FI844593A0 (fi) | 1984-11-22 |
| IE843148L (en) | 1985-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX156438A (es) | Procedimiento para la preparacion de un complejo mixto de tiazida y resina ionica | |
| ES2065885T3 (es) | Metodo de imprimacion de tejido duro. | |
| AR245365A1 (es) | Una composicion oral anticalculo. | |
| NZ334537A (en) | Two phase remineralising composition comprising a source of calcium ions and a source of phosphate ions with a water soluble polyphosphate salt | |
| EP0244178A3 (en) | Intraocular dosage compositions and method of use | |
| AU1861288A (en) | Radiation-sensitive mixture for photosensitive coating materials | |
| EP0210590A3 (en) | Polymeric additives for water | |
| DK342382A (da) | Fremgangsmaade til fremstilling af piperazinoner eller syreadditionssalte deraf og forbindelsernes anvendelse som laegemidler | |
| DE3460577D1 (en) | Sodium salt of ursodeoxycholic sulphate | |
| SE9002500L (sv) | Farmaceutisk, nac-innehaallande komposition foer oral administrering | |
| ES2149879T3 (es) | Adhesivo para dentaduras. | |
| DK1001792T3 (da) | Anvendelse af fysiologisk acceptable vanadiumforbindelser, -salte og -komplekser | |
| ES8305581A1 (es) | Un procedimiento para la preparacion de una composicion de un polimero de poli-(arilen-eter-sulfona) sulfonado. | |
| IE840977L (en) | Pharmaceutical preparations | |
| RU95119705A (ru) | Материал для пломбирования каналов корней зубов ("дентап-r") | |
| GB1511196A (en) | Creatinine pyrolidonecarboxylate | |
| Daelemans et al. | Calcium Carbonate as Phosphate Binder in Patients on Low-Calcium Dialysate | |
| GR1001523B (el) | Ενέσιμα διαλύματα του συνδυασμού παρακεταμόλης και κωδεϊνης. | |
| Abe et al. | Intermittent lithium administration for prophylaxis of periodic depression of puberty. | |
| DE3564423D1 (en) | Purification of 4-fluoro-4'-hydroxy-benzophenone | |
| Ishida et al. | Effects of So 42- and HCO 3- Upon the Artificial Waters Capable of Generating Pits on Aluminum | |
| FR2342726A1 (fr) | Nouvelles compositions diuretiques | |
| FR2160293A1 (en) | Aqueous poly(1,1'-dimethyl-1-sila-2,6-dioxa-4-hexanol) compsn - with antiinflammatory and reticuloendothelial activity | |
| Decker et al. | High-dose methotrexate with a safe rescue program | |
| JPS52119657A (en) | Method for preventing degrading of cationic high polymers of mannich type |